← Leaderboards
Emmanouhl Tzanakakis
State University Of New York At Buffalo
$1,944,796
Attributed
$1,944,796
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $379.7K · FY2008–14$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,944,796 · 2
By mechanism
R01$1,493,023 · 1
R21$451,773 · 1
Top collaborators
No co-investigators on record.
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Pinaki Sarder$7,231,909
- John K. Crane$2,928,037
- Satyanarayana Lakshminrusimha$5,665,508
Others in their field
Top investigators on “In Vitro Assay”
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,503,168
- David Heimbrook · Leidos Biomedical Research, Inc.$185,230,833
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$95,408,471
- Dennis R. Burton · Scripps Research Institute$83,128,308
- James W. Leduc · University Of Texas Med Br Galveston$68,033,800
Research focus
In Vitro AssayHuman Embryonic Stem CellInfarctionIn VitroHeart TransplantationAdoptedGene ProteinsHeart FailureHeart CellHeartAgitationBioprocessBioreactorsCardiacAdultDeveloped CountriesCause Of DeathExhibitsGrowthGenerationsClinically RelevantCellsBiochemicalMedical
Grant awards (8)
Bioprocess for cardiac cell generation from human induced pluripotent stem cells$200,485
R01 · FY2014 · HL · contact PI
Bioprocess for cardiac cell generation from human induced pluripotent stem cells$171,631
R01 · FY2014 · HL · contact PI
Bioprocess for cardiac cell generation from human induced pluripotent stem cells$361,485
R01 · FY2013 · HL · contact PI
Bioprocess for cardiac cell generation from human induced pluripotent stem cells$379,711
R01 · FY2012 · HL · contact PI
Bioprocess for cardiac cell generation from human induced pluripotent stem cells$379,711
R01 · FY2011 · HL · contact PI
Scalable bioprocess for cardiomyocyte generation from human embryonic stem cells$191,428
R21 · FY2009 · HL · contact PI
Scalable bioprocess for cardiomyocyte generation from human embryonic stem cells$68,917
R21 · FY2009 · HL · contact PI
Scalable bioprocess for cardiomyocyte generation from human embryonic stem cells$191,428
R21 · FY2008 · HL · contact PI